Insider · CIK 0001766042
Patricia C Hirano
officer
Files at SLNO (SOLENO THERAPEUTICS INC). First filing Jan 6, 2025, latest Jul 3, 2025.
In brief
Patricia C Hirano files SEC Form 4 as officer at SLNO (SOLENO THERAPEUTICS INC). Since Jan 6, 2025, Patricia C Hirano has reported 0 open-market buys worth $0 and 5 open-market sells worth $11M, the latest filed on Jul 3, 2025.
A track record needs three past buys with six months of prices behind them; Patricia C Hirano has 0, so none is measured yet.
The newest scored trade: sold $317k of SLNO on Jul 1, 2025, filed Jul 3, 2025, scored 14 (weak), under a 10b5-1 plan.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $11M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 14Weak | SOLENO THERAPEUTICS INC | $317k 3,830 shares | -22% | - | |
| 0Weak | SOLENO THERAPEUTICS INC | $22k 266 shares | -2% | - | |
| 28Weak | SOLENO THERAPEUTICS INC | $265k 3,782 shares | -12% | - | |
| 40Moderate | SOLENO THERAPEUTICS INC | $11M 156,315 shares | -139% | - | |
| 34Weak | SOLENO THERAPEUTICS INC | $139k 3,030 shares | -3% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 1, 2025 | SLNO SOLENO THERAPEUTICS, INC. | 3,830 0.01% of outstanding | $317k | Jul 1, 2025 | $22k |
| Jun 24, 2025 | SLNO SOLENO THERAPEUTICS, INC. | 266 0.00% of outstanding | $22k | Jun 24, 2025 | $11M |
| Apr 1, 2025 | SLNO SOLENO THERAPEUTICS, INC. | 3,782 0.01% of outstanding | $265k | Apr 1, 2025 | $11M |
| Mar 28, 2025 | SLNO SOLENO THERAPEUTICS, INC. | 27,662 0.06% of outstanding | $1.9M | Mar 28, 2025 | $8.9M |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | 23,375 0.05% of outstanding | $1.2M | Mar 27, 2025 | $139k |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS, INC. | 111,124 0.24% of outstanding | $7.6M | Mar 27, 2025 | $139k |
| Dec 14, 2023 | Soleno Therapeutics | 1,359 0.00% of outstanding | $51k | Dec 14, 2023 | none |
| Dec 14, 2023 | Soleno Therapeutics | 1,359 0.00% of outstanding | $51k | Dec 14, 2023 | none |
| Dec 14, 2023 | SLNO SOLENO THERAPEUTICS INC | 1,359 0.00% of outstanding | $51k | Dec 14, 2023 | none |
| Dec 13, 2023 | SLNO SOLENO THERAPEUTICS INC | 4,885 0.02% of outstanding | $190k | Dec 13, 2023 | $312k |
Transactions
The newest 50 of 53 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Common Stock | -22,702 | - | - | 0 | May 18, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -2,333 | - | - | 0 | May 18, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -18,842 | - | - | 0 | May 18, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -2,445 | - | - | 0 | May 18, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -11,667 | - | - | 0 | May 18, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -49,262 | - | - | 0 | May 18, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -16,000 | - | - | 0 | May 18, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -13,800 | - | - | 0 | May 18, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -11,900 | - | - | 0 | May 18, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Warrant (Right to buy)derivative | -1,333 | - | - | 0 | May 18, 2026 |
| Jan 21, 2026 | SLNO SOLENO THERAPEUTICS INC | AGrant or award Common Stock | +10,400 | $0.00 | $0 | 22,702 | Jan 23, 2026 |
| Jan 21, 2026 | SLNO SOLENO THERAPEUTICS INC | AGrant or award Employee stock option (right to buy)derivative | +11,900 | $0.00 | $0 | 11,900 | Jan 23, 2026 |
| Dec 15, 2025 | SLNO SOLENO THERAPEUTICS INC | FTax withholding Common Stock | -904 | $49.95 | $45k | 12,302 | Dec 17, 2025 |
| Jul 1, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -3,830 | $82.76 | $317k | 13,206 | Jul 3, 2025 |
| Jun 24, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock10b5-1 | +266 | $44.25 | $12k | 17,302 | Jun 26, 2025 |
| Jun 24, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -266 | $84.25 | $22k | 17,036 | Jun 26, 2025 |
| Jun 24, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -266 | $0.00 | $0 | 0 | Jun 26, 2025 |
| Apr 1, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -3,782 | $70.11 | $265k | 27,036 | Apr 2, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -1,418 | $65.97 | $94k | 110,884 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -2,310 | $66.79 | $154k | 108,574 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -4,199 | $67.70 | $284k | 104,375 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -5,524 | $68.79 | $380k | 98,851 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -3,198 | $69.84 | $223k | 95,653 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -329 | $70.73 | $23k | 95,324 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -478 | $71.74 | $34k | 94,846 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -73 | $72.64 | $5,303 | 94,773 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock10b5-1 | +6,000 | $24.00 | $144k | 100,773 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock10b5-1 | +4,400 | $25.05 | $110k | 105,173 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock10b5-1 | +4,888 | $5.10 | $25k | 110,061 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock10b5-1 | +13,333 | $2.60 | $35k | 123,394 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock10b5-1 | +8,333 | $2.41 | $20k | 131,727 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock10b5-1 | +35,186 | $5.25 | $185k | 166,913 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -46,214 | $66.39 | $3.1M | 120,699 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -24,776 | $67.47 | $1.7M | 95,923 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -24,989 | $70.18 | $1.8M | 70,934 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -15,145 | $72.50 | $1.1M | 55,789 | Mar 31, 2025 |
| Mar 28, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock10b5-1 | +2,691 | $33.60 | $90k | 58,480 | Mar 31, 2025 |
| Mar 28, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -3,394 | $67.46 | $229k | 55,086 | Mar 31, 2025 |
| Mar 28, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -12,324 | $68.92 | $849k | 42,762 | Mar 31, 2025 |
| Mar 28, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -9,253 | $69.52 | $643k | 33,509 | Mar 31, 2025 |
| Mar 28, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock10b5-1 | -2,691 | $73.60 | $198k | 30,818 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 0 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -4,400 | $0.00 | $0 | 0 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -4,888 | $0.00 | $0 | 2,445 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -13,333 | $0.00 | $0 | 0 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -8,333 | $0.00 | $0 | 11,667 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -35,186 | $0.00 | $0 | 49,262 | Mar 31, 2025 |
| Mar 28, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -2,691 | $0.00 | $0 | 18,842 | Mar 31, 2025 |
| Jan 21, 2025 | SLNO SOLENO THERAPEUTICS INC | AGrant or award Common Stock | +6,400 | $0.00 | $0 | 112,302 | Jan 23, 2025 |
| Jan 21, 2025 | SLNO SOLENO THERAPEUTICS INC | AGrant or award Employee stock option (right to buy)derivative | +13,800 | $0.00 | $0 | 13,800 | Jan 23, 2025 |
50 of 53 rows shown.
Questions about Patricia C Hirano
Answered from the filings on this page, as of the latest one.
Is Patricia C Hirano buying or selling?
Not in the last 12 months. Patricia C Hirano's latest open-market trade on SEC Form 4 was sold $317k of SLNO on Jul 1, 2025.
How did Patricia C Hirano's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Patricia C Hirano has 0.
Where does Patricia C Hirano file Form 4?
Patricia C Hirano has filed Form 4 at SLNO (SOLENO THERAPEUTICS INC) as SEE REMARKS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.